Tenaya Therapeutics, Inc. SEC filings TNYA
Tenaya Therapeutics, Inc. has 353 filings in SEC EDGAR's recent list, going back to May 7, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| DEFA14A | Additional proxy material | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 23, 2026 | Dec 9, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 13, 2026 | Dec 9, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 24, 2026 | — |
| 4 | Insider transaction | Aug 17, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 3 | Initial insider ownership | Jul 14, 2026 | Jul 13, 2026 |
| 4 | Insider transaction | Jul 14, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Agreement ended
|
Jul 2, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 29, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 18, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 27, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 5, 2026 | Mar 4, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 26, 2026 | — |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 144 | Notice of proposed sale | Feb 20, 2026 | — |
| 144 | Notice of proposed sale | Feb 20, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 12, 2026 | — |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 144 | Notice of proposed sale | Feb 11, 2026 | — |
| 144 | Notice of proposed sale | Feb 11, 2026 | — |
| 144 | Notice of proposed sale | Feb 10, 2026 | — |
| 144 | Notice of proposed sale | Feb 10, 2026 | — |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| S-8 | Employee stock plan registration | Feb 3, 2026 | — |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jan 30, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2026 | Dec 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 17, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 12, 2025 | Dec 11, 2025 |
| 424B5 | Prospectus supplement | Dec 12, 2025 | — |
| 424B5 | Prospectus supplement | Dec 11, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Other events
|
Nov 7, 2025 | Nov 7, 2025 |
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Sep 4, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2025 | — |
| 4 | Insider transaction | Aug 18, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 18, 2025 |
| 4 | Insider transaction | Aug 18, 2025 | Aug 18, 2025 |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 16, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 7, 2025 | — |
| 8-K |
Current report
Listing notice
|
Apr 18, 2025 | Apr 15, 2025 |
| ARS | Annual report to shareholders | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 17, 2025 | — |
| DEF 14A | Proxy statement | Apr 17, 2025 | May 28, 2025 |
| EFFECT | Filing | Mar 31, 2025 | — |
| 8-K |
Current report
Exit or restructuring costs
|
Mar 28, 2025 | Mar 27, 2025 |
| CORRESP | Letter to the SEC | Mar 27, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2025 | — |
| S-3 | Shelf registration | Mar 21, 2025 | — |
| 4 | Insider transaction | Mar 10, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 10, 2025 |
| 144 | Notice of proposed sale | Mar 10, 2025 | — |
| 144 | Notice of proposed sale | Mar 10, 2025 | — |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 7, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 7, 2025 | — |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 6, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Mar 4, 2025 | Mar 3, 2025 |
| 424B5 | Prospectus supplement | Mar 4, 2025 | — |
| 424B5 | Prospectus supplement | Mar 3, 2025 | — |
| 424B3 | Prospectus | Mar 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2025 | — |
| 3 | Initial insider ownership | Feb 7, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 6, 2025 |
| S-8 | Employee stock plan registration | Feb 7, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2025 | Feb 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2024 | Dec 16, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 21, 2024 | Oct 18, 2024 |
| S-8 | Employee stock plan registration | Sep 17, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 3 | Initial insider ownership | Aug 19, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 16, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 16, 2024 |
| 144 | Notice of proposed sale | Aug 16, 2024 | — |
| 144 | Notice of proposed sale | Aug 16, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 31, 2024 | May 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
May 14, 2024 | May 13, 2024 |
| ARS | Annual report to shareholders | Apr 17, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 17, 2024 | — |
| DEF 14A | Proxy statement | Apr 17, 2024 | May 30, 2024 |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 5, 2024 |
| 144 | Notice of proposed sale | Mar 5, 2024 | — |
| 4 | Insider transaction | Feb 27, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 20, 2024 |
| 144 | Notice of proposed sale | Feb 20, 2024 | — |
| 4 | Insider transaction | Feb 16, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 16, 2024 |
| 144 | Notice of proposed sale | Feb 16, 2024 | — |
| 144 | Notice of proposed sale | Feb 16, 2024 | — |
| 144 | Notice of proposed sale | Feb 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 14, 2024 | — |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 14, 2024 | Feb 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 424B5 | Prospectus supplement | Feb 8, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 8, 2024 | Feb 7, 2024 |
| S-8 | Employee stock plan registration | Jan 31, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 31, 2024 | — |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 4 | Insider transaction | Aug 29, 2023 | Aug 29, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TNYA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1858848
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.